- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
R
RPRX
Royalty Pharma Plc
32.60
0.41+1.27%After Hours: 32.80 +0.20 +0.61%18:20 04/17 EDT
OPEN/PREV CLOSE32.09/32.19
TODAY RANGE32.09-32.67
VOL2.54M
MARKET CAP18.72B
52 WEEK RANGE23.89-34.20
AVG VOL (3M)4.70M
% TURNOVER0.44%
TURNOVER--
P/E (TTM)17.05
% RANGE1.77%
EPS(TTM)1.912
P/E(FORWARD)15.90
P/B2.765
BVPS11.79
DIVIDEND0.8800
P/S8.48
BETA--
DIV YIELD2.70%
FREE FLOAT MKT CAP12.62B
SHARES OUTSTANDING574.31M
NEXT EARNINGS--
FREE FLOAT386.99M
LOT SIZE1
EX-DIV DATE02/21/2025
News
Press Releases
Financial Reports
Profile
TipRanks·04/10 20:32
Royalty Pharma Appoints Dr. Vlad Coric to Board
NASDAQ·04/10 10:20
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
TipRanks·04/08 20:40
Royalty Pharma appoints Biohaven CEO Vlad Coric to board
Reuters·04/08 20:15
ROYALTY PHARMA APPOINTS VLAD CORIC, M.D. TO THE COMPANY’S BOARD OF DIRECTORS
NASDAQ·04/01 10:20
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
TipRanks·03/28 10:40
Royalty Pharma pullback a buying opportunity, says Citi
TipRanks·03/27 13:27
Bank of America Securities Remains a Buy on Royalty Pharma (RPRX)
Reuters·03/27 12:15
ROYALTY PHARMA ANNOUNCES UPCOMING INVESTOR DAY
TipRanks·03/27 11:37
TD Cowen Reaffirms Their Buy Rating on Royalty Pharma (RPRX)
Benzinga·03/19 17:15
How Do Investors Really Feel About Royalty Pharma?
Simply Wall St·03/19 13:53
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Seeking Alpha·03/10 18:55
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
Same Industry
Name/Symbol
Change%
Price